Pharmacy and Poisons Board recalls cancer drug over safety
Health & Science
By
Stephanie Wangari
| Dec 06, 2024
The Pharmacy and Poisons Board has warned against using the cancer drug Flurasted 500 from Batch Number HHP24017, citing safety concerns.
In a statement posted on X on Thursday, the Board urged the public to cease using the drug immediately and to report any related issues.
“All pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public are directed to quarantine the affected batch immediately and halt its distribution, sale, issuance, or use,” the statement read.
The Board’s CEO, Fred Siyoi, explained that a market complaint regarding the appearance of the drug prompted the action.
READ MORE
Macadamia traders clash over AFA's alleged bias
47 ships reroute to Suez Canal since Feb
UAE investor inks Sh104b deal to expand Galana Kulalu project
Troubled Uchumi's creditors to know fate of their billions
Why tourism is Kenya's best bet to accelerate economic growth
BAT to pay Sh50 dividend despite 19pc profit dip
Appetite for Kenya's 'green gold' spawns new crop of millionaires
Policy Statement promises nothing unusual in CS Mbadi's first Budget
UNGA President Yang backs Equity's plan to boost youth innovation
Why you may not escape paying toll fees on major roads and highways
The public is encouraged to report suspected cases of substandard medicines or adverse drug reactions to the nearest healthcare facility or directly to the Pharmacy and Poisons Board.